Targeting CCK2R for pancreatic cancer chemoprevention

Gastrin signaling mediated through cholecystokinin-2 receptor (CCK2R) and its down-stream molecules is altered in pancreatic cancer. CCK2R antagonists, YF476 (netazepide) and JNJ-26070109, were tested systematically for their effect on pancreatic intraepithelial neoplasia (PanIN) progression to panc...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Mol Carcinog
Asıl Yazarlar: Mohammed, Altaf, Janakiram, Naveena B, Suen, Chen, Stratton, Nicole, Lightfoot, Stanley, Singh, Anil, Pathuri, Gopal, Ritchie, Rebekah, Madka, Venkateshwar, Rao, Chinthalapally V
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6721979/
https://ncbi.nlm.nih.gov/pubmed/31313401
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mc.23084
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller